GB8404584D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB8404584D0 GB8404584D0 GB848404584A GB8404584A GB8404584D0 GB 8404584 D0 GB8404584 D0 GB 8404584D0 GB 848404584 A GB848404584 A GB 848404584A GB 8404584 A GB8404584 A GB 8404584A GB 8404584 D0 GB8404584 D0 GB 8404584D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848404584A GB8404584D0 (en) | 1984-02-22 | 1984-02-22 | Compounds |
EP85101566A EP0152910B1 (de) | 1984-02-22 | 1985-02-13 | Pyrazolopyridinderivate |
DE8585101566T DE3571437D1 (de) | 1984-02-22 | 1985-02-13 | Pyrazolopyridine derivatives |
NZ211166A NZ211166A (en) | 1984-02-22 | 1985-02-20 | Pyrazolopyridines and pharmaceutical compositions |
CA000474776A CA1242714A (en) | 1984-02-22 | 1985-02-20 | Pyrazolopyridine derivatives |
AU38972/85A AU581207B2 (en) | 1984-02-22 | 1985-02-20 | Pyrazolopyridine derivatives |
ZA851281A ZA851281B (en) | 1984-02-22 | 1985-02-20 | Pyrazolopyridine derivatives |
GR850441A GR850441B (de) | 1984-02-22 | 1985-02-20 | |
ES540609A ES8606341A1 (es) | 1984-02-22 | 1985-02-21 | Un procedimiento para la preparacion de pirazolo piridinas. |
JP60031699A JPS60193987A (ja) | 1984-02-22 | 1985-02-21 | ピラゾロピリジン誘導体、その製法及びそれを含む医薬組成物 |
US06/852,152 US4670432A (en) | 1984-02-22 | 1986-04-15 | Pyrazolopyridine derivatives useful in treating inflammation and allergic conditions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848404584A GB8404584D0 (en) | 1984-02-22 | 1984-02-22 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB8404584D0 true GB8404584D0 (en) | 1984-03-28 |
Family
ID=10556988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB848404584A Pending GB8404584D0 (en) | 1984-02-22 | 1984-02-22 | Compounds |
Country Status (11)
Country | Link |
---|---|
US (1) | US4670432A (de) |
EP (1) | EP0152910B1 (de) |
JP (1) | JPS60193987A (de) |
AU (1) | AU581207B2 (de) |
CA (1) | CA1242714A (de) |
DE (1) | DE3571437D1 (de) |
ES (1) | ES8606341A1 (de) |
GB (1) | GB8404584D0 (de) |
GR (1) | GR850441B (de) |
NZ (1) | NZ211166A (de) |
ZA (1) | ZA851281B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT382377B (de) * | 1985-04-27 | 1987-02-25 | Beecham Group Plc | Verfahren zur herstellung von neuen 7-substituierten aminopyrazolo(4,3-b)pyridinen |
EP0239191A3 (de) * | 1986-01-30 | 1988-07-20 | Beecham Group Plc | Pyrazolo[4,3-b]pyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
GB8609421D0 (en) * | 1986-04-17 | 1986-05-21 | Beecham Group Plc | Compounds |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
EP1377573B1 (de) * | 2000-12-15 | 2005-07-27 | Glaxo Group Limited | Pyrazolopyridinderivate |
US6919352B2 (en) | 2000-12-15 | 2005-07-19 | Smithkline Beecham Corporation | Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds |
AU2002248531A1 (en) * | 2001-03-08 | 2002-09-24 | Smithkline Beecham Corporation | Pyrazolopyriadine derivatives |
WO2002078701A1 (en) * | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Use of pyrazolopyridines as therapeutic compounds |
WO2002078700A1 (en) | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Pyralopyridines, process for their preparation and use as therapteutic compounds |
ATE332301T1 (de) * | 2001-04-10 | 2006-07-15 | Smithkline Beecham Corp | Antivirale pyrazolopyridin verbindungen |
WO2002088124A2 (en) * | 2001-04-27 | 2002-11-07 | Smithkline Beecham Corporation | Pyrazolo'1,5-a!pyridine derivatives |
CN1518550A (zh) * | 2001-06-21 | 2004-08-04 | ʷ��˿�������ȳ�ķ����˾ | 用于预防和治疗疱疹病毒感染的咪唑并[1,2-a]吡啶衍生物 |
EP1423389B1 (de) * | 2001-09-07 | 2007-06-06 | SmithKline Beecham Corporation | Pyrazolo-pyridine für die behandlung von herpes-ansteckungen |
EP1432712B1 (de) * | 2001-10-05 | 2006-05-17 | SmithKline Beecham Corporation | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion |
ATE373000T1 (de) * | 2001-12-11 | 2007-09-15 | Smithkline Beecham Corp | Pyrazolopyridin-derivate als antiherpesmittel |
EP1546148A1 (de) * | 2002-10-03 | 2005-06-29 | SmithKline Beecham Corporation | Auf pyrazolopyridinderivaten basierende therapeutische verbindungen |
US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
TW200538453A (en) | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
US7432373B2 (en) | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
US7173031B2 (en) | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
WO2007035428A1 (en) | 2005-09-15 | 2007-03-29 | Bristol-Myers Squibb Company | Met kinase inhibitors |
US7547782B2 (en) | 2005-09-30 | 2009-06-16 | Bristol-Myers Squibb Company | Met kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4048184A (en) * | 1976-11-15 | 1977-09-13 | E. R. Squibb & Sons, Inc. | 6-Phenyl-2H-pyrazolo[3,4-b]pyridines |
DE3464368D1 (de) * | 1983-03-09 | 1987-07-30 | Beecham Group Plc | Anti-inflammatory pyrazolo pyridines |
EP0151962A3 (de) * | 1984-01-25 | 1985-10-02 | Beecham Group Plc | Pyrazolopyridin-Derivate |
EP0193329A3 (de) * | 1985-02-22 | 1987-08-19 | Beecham Group Plc | Pyrazolopyridine, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen |
-
1984
- 1984-02-22 GB GB848404584A patent/GB8404584D0/en active Pending
-
1985
- 1985-02-13 EP EP85101566A patent/EP0152910B1/de not_active Expired
- 1985-02-13 DE DE8585101566T patent/DE3571437D1/de not_active Expired
- 1985-02-20 GR GR850441A patent/GR850441B/el unknown
- 1985-02-20 AU AU38972/85A patent/AU581207B2/en not_active Ceased
- 1985-02-20 ZA ZA851281A patent/ZA851281B/xx unknown
- 1985-02-20 CA CA000474776A patent/CA1242714A/en not_active Expired
- 1985-02-20 NZ NZ211166A patent/NZ211166A/en unknown
- 1985-02-21 JP JP60031699A patent/JPS60193987A/ja active Pending
- 1985-02-21 ES ES540609A patent/ES8606341A1/es not_active Expired
-
1986
- 1986-04-15 US US06/852,152 patent/US4670432A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3571437D1 (de) | 1989-08-17 |
NZ211166A (en) | 1988-01-08 |
AU3897285A (en) | 1985-08-29 |
EP0152910B1 (de) | 1989-07-12 |
AU581207B2 (en) | 1989-02-16 |
ES540609A0 (es) | 1986-04-16 |
US4670432A (en) | 1987-06-02 |
EP0152910A3 (en) | 1986-07-16 |
ZA851281B (en) | 1985-11-27 |
GR850441B (de) | 1985-06-19 |
EP0152910A2 (de) | 1985-08-28 |
CA1242714A (en) | 1988-10-04 |
JPS60193987A (ja) | 1985-10-02 |
ES8606341A1 (es) | 1986-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3569932D1 (en) | Cotelomer compounds | |
GB8404584D0 (en) | Compounds | |
GB8404586D0 (en) | Compounds | |
GB8417171D0 (en) | Compounds | |
GB8415540D0 (en) | Imidazoisoquinoline compounds | |
GB8415377D0 (en) | Compounds | |
GB8418657D0 (en) | Compounds | |
GB8406689D0 (en) | Compounds | |
GB8402086D0 (en) | Compounds | |
GB8419103D0 (en) | Compounds | |
GB8412862D0 (en) | Compounds | |
GB8401868D0 (en) | Compounds | |
GB8403464D0 (en) | Compounds | |
GB8414647D0 (en) | Compounds | |
GB8404047D0 (en) | Compounds | |
GB8404587D0 (en) | Compounds | |
GB8404588D0 (en) | Compounds | |
GB8405955D0 (en) | Compounds | |
GB8415313D0 (en) | Compounds | |
GB8407024D0 (en) | Compounds | |
GB8407708D0 (en) | Compounds | |
GB8408322D0 (en) | Compounds | |
GB8409699D0 (en) | Compounds | |
GB8409987D0 (en) | Compounds | |
GB8411560D0 (en) | Compounds |